Regulation of tumor suppressors by nuclear-cytoplasmic shuttling.
暂无分享,去创建一个
[1] Utz Fischer,et al. The HIV-1 Rev Activation Domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs , 1995, Cell.
[2] D. Woods,et al. C-Terminal Ubiquitination of p53 Contributes to Nuclear Export , 2001, Molecular and Cellular Biology.
[3] B. Henderson. Nuclear-cytoplasmic shuttling of APC regulates β-catenin subcellular localization and turnover , 2000, Nature Cell Biology.
[4] S. Fang,et al. RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[5] Karsten Weis,et al. Exportin 1 (Crm1p) Is an Essential Nuclear Export Factor , 1997, Cell.
[6] V. Rotter,et al. Nuclear accumulation of p53 protein is mediated by several nuclear localization signals and plays a role in tumorigenesis , 1990, Molecular and cellular biology.
[7] A. Levine,et al. Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[8] Y. Xiong,et al. A p53 Amino-Terminal Nuclear Export Signal Inhibited by DNA Damage-Induced Phosphorylation , 2001, Science.
[9] C. Osborne,et al. Aberrant Subcellular Localization of BRCA1 in Breast Cancer , 1995, Science.
[10] Stephen Lee,et al. Oxygen-Dependent Ubiquitination and Degradation of Hypoxia-Inducible Factor Requires Nuclear-Cytoplasmic Trafficking of the von Hippel-Lindau Tumor Suppressor Protein , 2002, Molecular and Cellular Biology.
[11] J. Moroianu,et al. Nuclear import and export: transport factors, mechanisms and regulation. , 1999, Critical reviews in eukaryotic gene expression.
[12] Raymond L. White,et al. Cell Density and Phosphorylation Control the Subcellular Localization of Adenomatous Polyposis Coli Protein , 2001, Molecular and Cellular Biology.
[13] J. Trent,et al. WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.
[14] B. E. Black,et al. Calreticulin Is a Receptor for Nuclear Export , 2001, The Journal of cell biology.
[15] C. Dargemont,et al. Evidence for a role of CRM1 in signal-mediated nuclear protein export. , 1997, Science.
[16] Sven Berg,et al. A repeating amino acid motif shared by proteins with diverse cellular roles , 1994, Cell.
[17] Wei Gu,et al. Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain , 1997, Cell.
[18] K. Tsai,et al. An intact HDM2 RING-finger domain is required for nuclear exclusion of p53 , 2000, Nature Cell Biology.
[19] D. Livingston,et al. Functional communication between endogenous BRCA1 and its partner, BARD1, during Xenopus laevis development , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[20] Charles J. Sherr,et al. Nucleolar Arf sequesters Mdm2 and activates p53 , 1999, Nature Cell Biology.
[21] M. Clarke,et al. Cooperation of a Single Lysine Mutation and a C-terminal Domain in the Cytoplasmic Sequestration of the p53 Protein* , 1998, The Journal of Biological Chemistry.
[22] H. Clevers,et al. APC, Signal transduction and genetic instability in colorectal cancer , 2001, Nature Reviews Cancer.
[23] Raymond L. White,et al. APC‐mediated downregulation of β‐catenin activity involves nuclear sequestration and nuclear export , 2000, EMBO reports.
[24] E. Nishida,et al. Regulation of intracellular dynamics of Smad4 by its leucine‐rich nuclear export signal , 2000, EMBO reports.
[25] B. Levine,et al. Beclin 1 contains a leucine-rich nuclear export signal that is required for its autophagy and tumor suppressor function. , 2001, Cancer research.
[26] T. Pollard,et al. Wild-type but not mutant APC associates with the microtubule cytoskeleton. , 1994, Cancer research.
[27] Minoru Yoshida,et al. CRM1 is responsible for intracellular transport mediated by the nuclear export signal , 1997, Nature.
[28] M. Clarke,et al. A Bipartite Nuclear Localization Signal Is Required for p53 Nuclear Import Regulated by a Carboxyl-terminal Domain* , 1999, The Journal of Biological Chemistry.
[29] G. Dreyfuss,et al. The K nuclear shuttling domain: a novel signal for nuclear import and nuclear export in the hnRNP K protein , 1997, The EMBO journal.
[30] J. Berthelsen,et al. The subcellular localization of PBX1 and EXD proteins depends on nuclear import and export signals and is modulated by association with PREP1 and HTH. , 1999, Genes & development.
[31] B. Gumbiner,et al. Nuclear localization signal-independent and importin/karyopherin-independent nuclear import of β-catenin , 1998, Current Biology.
[32] Rachel E. Klevit,et al. Structure of a BRCA1–BARD1 heterodimeric RING–RING complex , 2001, Nature Structural Biology.
[33] Simak Ali,et al. An important role for BRCA1 in breast cancer progression is indicated by its loss in a large proportion of non‐familial breast cancers , 1998, International journal of cancer.
[34] H. Ruffner,et al. Cancer-predisposing mutations within the RING domain of BRCA1: Loss of ubiquitin protein ligase activity and protection from radiation hypersensitivity , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[35] P. Silver,et al. Nucleocytoplasmic transport of macromolecules , 1997, Microbiology and molecular biology reviews : MMBR.
[36] D. Woods,et al. Regulation of p53 function. , 2001, Experimental cell research.
[37] D. Wiederschain,et al. Identification of p53 Sequence Elements That Are Required for MDM2-Mediated Nuclear Export , 2001, Molecular and Cellular Biology.
[38] Anne M. Bowcock,et al. Identification of a RING protein that can interact in vivo with the BRCA1 gene product , 1996, Nature Genetics.
[39] William D. Richardson,et al. A short amino acid sequence able to specify nuclear location , 1984, Cell.
[40] Wen-Hwa Lee,et al. Identification of a Novel Cytoplasmic Protein That Specifically Binds to Nuclear Localization Signal Motifs* , 1998, The Journal of Biological Chemistry.
[41] W. Linehan,et al. Detection of von Hippel-Lindau disease gene mutations in paraffin-embedded sporadic renal cell carcinoma specimens. , 1996, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[42] Shoichiro Tsukita,et al. Adenomatous Polyposis Coli (APC) Protein Moves along Microtubules and Concentrates at Their Growing Ends in Epithelial Cells , 2000, The Journal of cell biology.
[43] R. Klausner,et al. Nuclear/cytoplasmic localization of the von Hippel-Lindau tumor suppressor gene product is determined by cell density. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[44] L. Poellinger,et al. Mechanism of regulation of the hypoxia‐inducible factor‐1α by the von Hippel‐Lindau tumor suppressor protein , 2000, The EMBO journal.
[45] K. Kinzler,et al. The multistep nature of cancer. , 1993, Trends in genetics : TIG.
[46] T. Shuin,et al. Tumor suppressor protein VHL is induced at high cell density and mediates contact inhibition of cell growth , 2001, Oncogene.
[47] Thomas Ludwig,et al. The BRCA1/BARD1 heterodimer, a tumor suppressor complex with ubiquitin E3 ligase activity. , 2002, Current opinion in genetics & development.
[48] R. White,et al. Nuclear and cytoplasmic localizations of the adenomatous polyposis coli protein. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[49] Xin Lu,et al. RB regulates the stability and the apoptotic function of p53 via MDM2. , 1999, Molecular cell.
[50] Erich A. Nigg,et al. Nucleocytoplasmic transport: signals, mechanisms and regulation , 1997, Nature.
[51] J. Steitz,et al. HNS, a nuclear-cytoplasmic shuttling sequence in HuR. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[52] Yumay Chen,et al. The Nuclear Localization Sequences of the BRCA1 Protein Interact with the Importin-α Subunit of the Nuclear Transport Signal Receptor* , 1996, The Journal of Biological Chemistry.
[53] John Calvin Reed,et al. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene , 1995, Cell.
[54] S. Elledge,et al. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases , 1993, Cell.
[55] B. Henderson,et al. A comparison of the activity, sequence specificity, and CRM1-dependence of different nuclear export signals. , 2000, Experimental cell research.
[56] P. Polakis,et al. The APC gene product associates with microtubules in vivo and promotes their assembly in vitro. , 1994, Cancer research.
[57] B. Cullen,et al. Adenomatous polyposis coli protein contains two nuclear export signals and shuttles between the nucleus and cytoplasm. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[58] M. Yaniv,et al. Purification and biochemical heterogeneity of the mammalian SWI‐SNF complex. , 1996, The EMBO journal.
[59] D. Livingston,et al. In search of the tumour-suppressor functions of BRCA1 and BRCA2 , 2000, Nature.
[60] Jeremy R Stuart,et al. Nuclear Import and Export Signals in Control of the p53-related Protein p73* , 2002, The Journal of Biological Chemistry.
[61] G. Wahl,et al. A leucine‐rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking , 1999, The EMBO journal.
[62] J. Węsierska‐Gądek,et al. ADP‐ribosylation of p53 tumor suppressor protein: Mutant but not wild‐type p53 is modified , 1996, Journal of cellular biochemistry.
[63] P. Silver,et al. Diverse nuclear transport pathways regulate cell proliferation and oncogenesis. , 2000, Biochimica et biophysica acta.
[64] T. Ouchi,et al. Autoubiquitination of the BRCA1·BARD1 RING Ubiquitin Ligase* , 2002, The Journal of Biological Chemistry.
[65] P. Shaw,et al. Regulation of specific DNA binding by p53: evidence for a role for O-glycosylation and charged residues at the carboxy-terminus. , 1996, Oncogene.
[66] L. Saucedo,et al. p76MDM2 Inhibits the Ability of p90MDM2to Destabilize p53* , 2000, The Journal of Biological Chemistry.
[67] D. Lane,et al. An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo , 2000, Oncogene.
[68] C. Xiao,et al. Nuclear targeting signal recognition: a key control point in nuclear transport? , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.
[69] Minoru Yoshida,et al. CRM1 Is an Export Receptor for Leucine-Rich Nuclear Export Signals , 1997, Cell.
[70] C. Maki,et al. The MDM2 RING-finger domain is required to promote p53 nuclear export , 2000, Nature Cell Biology.
[71] Stephen Lee,et al. Ran-mediated Nuclear Export of the von Hippel-Lindau Tumor Suppressor Protein Occurs Independently of Its Assembly with Cullin-2* , 2000, The Journal of Biological Chemistry.
[72] J. Rodriguez,et al. Identification of a Functional Nuclear Export Sequence in BRCA1* , 2000, The Journal of Biological Chemistry.
[73] G. Kalpana,et al. A masked NES in INI1/hSNF5 mediates hCRM1‐dependent nuclear export: implications for tumorigenesis , 2002, The EMBO journal.
[74] R. Klausner,et al. Transcription-Dependent Nuclear-Cytoplasmic Trafficking Is Required for the Function of the von Hippel-Lindau Tumor Suppressor Protein , 1999, Molecular and Cellular Biology.
[75] R. Laskey,et al. Nuclear targeting sequences--a consensus? , 1991, Trends in biochemical sciences.
[76] G. Dreyfuss,et al. A nuclear export signal in hnRNP A1: A signal-mediated, temperature-dependent nuclear protein export pathway , 1995, Cell.
[77] A. Knudson,et al. Antioncogenes and human cancer. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[78] E. Appella,et al. Post-translational modifications and activation of p53 by genotoxic stresses. , 2001, European journal of biochemistry.
[79] B. Cullen,et al. Protein sequence requirements for function of the human T-cell leukemia virus type 1 Rex nuclear export signal delineated by a novel in vivo randomization-selection assay , 1996, Molecular and cellular biology.
[80] T. Ohta,et al. The RING Heterodimer BRCA1-BARD1 Is a Ubiquitin Ligase Inactivated by a Breast Cancer-derived Mutation* , 2001, The Journal of Biological Chemistry.
[81] F. Couch,et al. Localization of BRCA1 and a splice variant identifies the nuclear localization signal , 1997, Molecular and cellular biology.
[82] J. Vonesch,et al. Negative cross‐talk between p53 and the glucocorticoid receptor and its role in neuroblastoma cells , 2000, The EMBO journal.
[83] A. Levine,et al. Nucleocytoplasmic shuttling of oncoprotein Hdm2 is required for Hdm2-mediated degradation of p53. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[84] A. Ciechanover,et al. c-Abl Regulates p53 Levels under Normal and Stress Conditions by Preventing Its Nuclear Export and Ubiquitination , 2001, Molecular and Cellular Biology.
[85] Mariann Bienz,et al. The APC tumour suppressor has a nuclear export function , 2000, Nature.
[86] D. Görlich. Transport into and out of the cell nucleus , 1998, The EMBO journal.
[87] Y. Wang,et al. Leptomycin B is an inhibitor of nuclear export: inhibition of nucleo-cytoplasmic translocation of the human immunodeficiency virus type 1 (HIV-1) Rev protein and Rev-dependent mRNA. , 1997, Chemistry & biology.
[88] B. Henderson,et al. ARM Domain-dependent Nuclear Import of Adenomatous Polyposis Coli Protein Is Stimulated by the B56α Subunit of Protein Phosphatase 2A* , 2001, The Journal of Biological Chemistry.
[89] M. Clarke,et al. The nuclear import of p53 is determined by the presence of a basic domain and its relative position to the nuclear localization signal , 1999, Oncogene.
[90] A. Levine,et al. Nucleo‐cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein , 1998, The EMBO journal.
[91] T. Crook,et al. A transforming p53 mutant, which binds DNA, transactivates and induces apoptosis reveals a nuclear:cytoplasmic shuttling defect , 1998, Oncogene.
[92] S. Karki,et al. Cytoplasmic dynein and dynactin in cell division and intracellular transport. , 1999, Current opinion in cell biology.
[93] G. Blobel,et al. Transport routes through the nuclear pore complex. , 1998, Current opinion in cell biology.
[94] L. Litovchick,et al. Nucleocytoplasmic Shuttling of p130/RBL2: Novel Regulatory Mechanism , 2002, Molecular and Cellular Biology.
[95] J. Rodriguez,et al. BARD1 Induces BRCA1 Intranuclear Foci Formation by Increasing RING-dependent BRCA1 Nuclear Import and Inhibiting BRCA1 Nuclear Export* , 2002, The Journal of Biological Chemistry.
[96] C. Hill,et al. Transforming Growth Factor β-Independent Shuttling of Smad4 between the Cytoplasm and Nucleus , 2000, Molecular and Cellular Biology.
[97] B. Karlan,et al. Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas , 1999, Nature Genetics.
[98] H. de Thé,et al. PML protein expression in hematopoietic and acute promyelocytic leukemia cells. , 1993, Blood.
[99] J. Węsierska‐Gądek,et al. ADP-ribosylation of wild-type p53 in vitro: binding of p53 protein to specific p53 consensus sequence prevents its modification. , 1996, Biochemical and biophysical research communications.
[100] M. Oren,et al. mdm2 expression is induced by wild type p53 activity. , 1993, The EMBO journal.
[101] A. Tyner,et al. Functional analysis and intracellular localization of p53 modified by SUMO-1 , 2001, Oncogene.
[102] M. Yanagida,et al. Leptomycin B inhibition of signal-mediated nuclear export by direct binding to CRM1. , 1998, Experimental cell research.
[103] G. Blobel,et al. The GTP-binding protein Ran/TC4 is required for protein import into the nucleus , 1993, Nature.
[104] F. McKeon,et al. NF-AT activation requires suppression of Crm1-dependent export by calcineurin , 1999, Nature.